$BURUD NUBURU Issues Shareholder Letter on Strategic

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
148
$BURUD NUBURU Issues Shareholder Letter on Strategic Progress and NYSE American Appeal

Executive Chairman and Co-Chief Executive Officer Alessandro Zamboni discusses split-adjusted OTC trading, Tekne closing progress and execution of NUBURU’s dual-use Defense & Security platform

DENVER--(BUSINESS WIRE)--NUBURU, Inc. (OTC Pink: BURUD) ("NUBURU" or the "Company" , a next-generation dual-use Defense & Security integrated platform company, today issued the following letter to shareholders from Alessandro Zamboni, Executive Chairman and Co-Chief Executive Officer.

Dear Fellow Shareholders,

NUBURU common stock is expected to begin trading today on a split-adjusted basis on the OTC Pink Market under the temporary symbol “BURUD,” following the 1-for-40 reverse stock split that became effective at 4:30 p.m. Eastern Time on September 1, 2026. The “D” suffix is expected to remain for 20 business days, after which the common stock is expected to resume trading on the OTC Pink Market under its base symbol, “BURU.” The reverse split is a mechanical change: it reduces the number of shares outstanding and proportionately adjusts the per-share reference price, while the market determines the trading price thereafter. Subject to the fractional-share treatment previously disclosed, it does not by itself change a shareholder’s proportional ownership or create economic value.

The reverse split was undertaken to address price-related considerations in the pending NYSE American appeal; it does not ensure compliance or resumption of trading. We believe shareholder value must come from execution: completing the proposed Tekne transaction, integrating complementary capabilities into one platform, converting opportunities into contracts and cash, and strengthening NUBURU’s capital structure.

NYSE American Process

NUBURU’s common stock remains listed on NYSE American under the symbol “BURU” pending completion of the appeal process, although trading on NYSE American remains suspended. The Company is in active dialogue with NYSE Regulation regarding the path to a potential resumption of trading. Any resumption remains subject to NYSE Regulation’s determination and completion of applicable corporate-action notice procedures. No decision has been made, NYSE Regulation has not provided the Company with a specific sustained post-split trading-price threshold or duration for a potential resumption of trading, and there can be no assurance whether or when trading on NYSE American will resume. We will report material developments as they occur.

Tekne: Closing Progress and Industrial Scale

As detailed in our September 1, 2026 release, NUBURU and the other parties are advancing the remaining steps toward the Company’s proposed acquisition of a 70% controlling interest in Tekne S.p.A. following the Italian Government’s Golden Power authorization on August 5, 2026. Based on current progress, NUBURU expects closing during the first half of October 2026, subject to completion of the remaining closing actions.

That release also reported Tekne management’s preliminary, unaudited review of its customer order portfolio, which indicated approximately $135.4 million in adjusted active remaining order value. That figure is management-derived, represents 100% of Tekne, remains subject to NUBURU’s customary closing verification, is not a measure defined under U.S. GAAP and does not represent recognized revenue, guaranteed future revenue, cash collections or financial guidance. It nonetheless provides a measurable operating benchmark against which shareholders can assess conversion into revenue and cash.

Building One Scalable Platform

Upon closing, Tekne is expected to add industrial depth in special vehicles, defense mobility, electronic systems, EW/CEMA and mission-package integration. NUBURU Defense Italy S.r.l. (“NDI”) is intended to coordinate the Group’s Italian activities and serve as an integration and governance hub, and NUBURU has initiated recruitment for a Chief Platform Officer to lead the common technical roadmap, architecture and cross-company productization. Within NDI, the planned Platform Integration and Software Factory, or “Platform Factory,” would be an integration and productization function rather than a separate manufacturing facility.

Our objective is a repeatable, multi-year model combining software licenses and subscriptions; hardware support, maintenance and upgrades; and integration, engineering and lifecycle services. These are strategic objectives, not contracted revenue or financial guidance.

Persistent Readiness and Strategic Alignment

Security requirements increasingly extend across peacetime, crisis and conflict, requiring persistent situational awareness, resilient communications, operational continuity and rapid adaptation. Allied defense and security investment in the United States and Europe is rising against that backdrop, and the August 2026 U.S. National Security Science and Technology Strategy identifies advanced manufacturing and materials, artificial intelligence and autonomy, communications and networking, directed energy, information management and cybersecurity, sensing and signature management, and space technologies among its priority areas. NUBURU believes its dual-use, multi-layer and multi-domain roadmap is directionally aligned with several of these themes. This is the Company’s own assessment and does not constitute government endorsement, qualification, an award, an order or a funding commitment, and our opportunity depends in each case on customer priorities, procurement, competition, funding and execution.

What Shareholders Should Measure

Tekne — closing the proposed transaction, implementing governance, and reporting disciplined conversion of orders into revenue and cash;

Platform execution — forming and operationalizing NDI, recruiting the Chief Platform Officer, advancing the Platform Factory and securing customer validation and contractual awards; and

Financial and capital-markets discipline — liquidity, capital allocation, dilution management and transparent updates regarding the NYSE American appeal.

Thank you for your patience and engagement. We believe NUBURU is assembling a strategically relevant platform as defense, infrastructure and digital-resilience needs converge. We also know that belief does not create value. We ask to be evaluated by milestones, contracts, revenue, cash and disciplined delivery — not by the arithmetic of a reverse split or a single trading day.

Sincerely,

Alessandro Zamboni

Executive Chairman and Co-Chief Executive Officer

About NUBURU, Inc.

NUBURU, Inc. (OTC Pink: BURUD) is a next-generation dual-use Defense & Security integrated platform company developing software-orchestrated, hardware-enabled capabilities for defense and security, critical infrastructure and digital-resilience markets. Its strategy includes directed-energy and non-kinetic effects, EW/CEMA, defense mobility, operational-resilience software and advanced deployable manufacturing. Following the temporary 20-business-day post-split period, the Company’s common stock is expected to resume trading on the OTC Pink Market under the symbol “BURU.” For more information, visit https://ir.nuburu.net/corporate-profile/default.aspx.

Forward-Looking Statements

This shareholder letter contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the commencement of split-adjusted OTC trading, the temporary and post-transition trading symbols and the reverse stock split; the NYSE American appeal, review process and possible resumption of trading; the timing and completion of the Tekne transaction; support provided to Tekne; Tekne’s order portfolio and conversion to revenue or cash; NDI, the Chief Platform Officer and Platform Factory; platform integration, customer adoption and potential recurring or lifecycle revenue; market opportunities; and U.S., EU, NATO and allied priorities.

Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, including delays or changes in market processing or the ticker-symbol transition; OTC-market liquidity and volatility; a post-split price decline or failure of the reverse split to achieve its purposes; delay or an adverse NYSE American outcome, including failure to satisfy NYSE Regulation or complete required procedures; delay or failure to close the Tekne transaction; changes in funding or consideration and the recoverability or treatment of support provided to Tekne; the preliminary, unaudited and non-U.S.-GAAP nature of Tekne information; differences among order measures; order modification, delay, cancellation, customer acceptance and collection risks; inability to form, staff or operationalize NDI or the Platform Factory; failure to recruit leadership, validate technology, win contracts or generate recurring revenue; government-procurement, competition, cybersecurity, supply-chain, export-control and regulatory risks; the possibility that allied defense initiatives do not produce eligible opportunities or awards; operating losses, negative cash flow, financing needs and dilution; and other risks in NUBURU’s SEC filings. Readers should not place undue reliance on forward-looking statements, which speak only as of their date. NUBURU undertakes no obligation to update them except as required by law. This letter is not investment advice, an offer to sell or a solicitation of an offer to buy securities.

https://www.businesswire.com/news/home/202609...can-Appeal

Nuburu Inc. (BURU) Stock Research Links

BURU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Express Europe Partners with Formag for Logistics Support

Updated Category News Views 213

Nippon Express Europe and Formag Form New Logistics Partnership Nippon Express Europe GmbH, part of NIPPON EXPRESS HOLDINGS, INC., has recently signed a cooperation agreement with Ukrainian logistics provider, Formag-Kiev. This significant collaboration aims to provide essential logistical support for the reconstruction of Ukraine. Commitment to Ukrainian Reconstruction...

Continue Reading
Escalating Legal Action Over LIBRA Token Sparks Controversy

Updated Category News Views 265

Legal Developments in the LIBRA Token Case A prominent Argentine lawyer has made headlines by calling for global law enforcement to apprehend a cryptocurrency figure involved in the LIBRA token controversy. Details of the Extradition Request Gregorio Dalbon, known for his defense work with former Argentine President Cristina Fernandez in a prominent corruption matter, has...

Continue Reading
Tesla Prevails in Motion to Dismiss Racial Bias Lawsuit

Updated Category News Views 230

Tesla's Legal Victory Against Racial Bias Allegations Under the direction of Elon Musk, Tesla Inc. (NASDAQ: TSLA) has successfully overturned a significant class action lawsuit that was brought forth by more than 6,000 African American workers. These workers alleged racial discrimination at Tesla's Fremont assembly plant. This ruling is a key moment in the ongoing...

Continue Reading
ZenaTech Unveils Specialized AI Hub to Bolster US Defense Tactics

Updated Category News Views 100

ZenaTech Launches Innovative AI Development Center Vancouver, British Columbia – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) has taken a significant stride toward advancing artificial intelligence technologies by establishing Zena AI, Inc. This new AI Development Center will focus on crafting specialized AI solutions tailored for defense and homeland security...

Continue Reading
Investors Reminded of Action Timeline Against ICON plc - ICLR

Updated Category News Views 172

Understanding the Legal Proceedings Against ICON plc In an important reminder for shareholders, Kahn Swick & Foti, LLC is emphasizing the critical timeline for investors affected by losses from their holdings in ICON plc (NASDAQ: ICLR). The firm, led by former Louisiana Attorney General Charles C. Foti, Jr., is urging investors who incurred losses exceeding $100,000 to...

Continue Reading